Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ATI-5261

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Peptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Apolipoprotein A1 mimetic peptide ATI-5261 reverses arterial stiffness at late pregnancy and early postpartum in a COMT−/− mouse model of preeclampsia
BackgroundPreeclampsia (PE) is a serious maternal complication during pregnancy. Associated arterial stiffness in PE patients… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2015
2015
Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro
Apolipoprotein (apo) mimetic peptides replicate some aspects of HDL function. We have previously reported the effects of compound… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
Apolipoprotein E derived HDL mimetic peptide ATI-5261 promotes nascent HDL formation and reverse cholesterol transport in vitro.
Modulation of the reverse cholesterol transport (RCT) pathway may provide a therapeutic target for the prevention and treatment… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
Abstract 626: The ABCA1 Agonist Peptides CS-6253 and ATI-5261 Replicate ApoA-I Function and Generate nHDL Particles that Are Remodeled and Maturated Within the Plasma Compartment, Resulting in…
Novel apolipoprotein (apo) mimetic peptides are potent mediators of ABCA1-mediated cholesterol efflux, mimicking native apoA-I… Expand
Is this relevant?
2013
2013
Abstract 402: HDL Mimetic Peptides ATI-5261 and CS-6253 Induce ABCA1 Oligomerization, Cellular Cholesterol Efflux and Generate Nascent HDL-Like Lipoproteins
Novel approaches that target HDL biogenesis may increase nascent HDL-like particle formation that can be used for therapeutic… Expand
Is this relevant?
2013
2013
Abstract 13853: Biological Action of ABCA1 Ligand Peptide ATI-5261 and its Analogs With Improved Safety Features
Recent studies have produced apolipoprotein (apo) mimetic peptides that reduce substantial atherosclerosis in animal models when… Expand
Is this relevant?
2013
2013
Abstract 14760: Apolipoprotein (apo) Mimetic Peptides ATI-5261 and CS-6253 Induce ABCA1/ABCG1 Mediated HDL Formation and Maturation in a Process Including ABCA1 Oligomerization and LCAT in Way…
Two novel (26-AA) apolipoprotein (apo) mimetic peptides ATI-5261 and CS-6253 were studied in vitro for their ability to interact… Expand
Is this relevant?
2012
2012
The positional specificity of EXXK motifs within an amphipathic α-helix dictates preferential lysine modification by acrolein: implications for the design of high-density lipoprotein mimetic peptides…
Despite the ability of acrolein to damage proteins, factors governing its reactivity with the ε-amino group of lysine are poorly… Expand
Is this relevant?
2011
2011
HDL mimetic peptide ATI-5261 forms an oligomeric assembly in solution that dissociates to monomers upon dilution.
ATI-5261 is a 26-mer peptide that stimulates cellular cholesterol efflux with high potency. This peptide displays high aqueous… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2010
Highly Cited
2010
A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice
Here, we report the creation of a single-helix peptide (ATI-5261) that stimulates cellular cholesterol efflux with Km molar… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE